Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Marketwire (May 10, 2013)
-
-
-
-
-
-
-
-
-
Marketwire (Apr 18, 2013)
-
-
-
-
AVI BioPharma, Inc. Q2 2008 Earnings Call TranscriptMon, Aug 11, 2008
-
AVI BioPharma, Inc.Q4 2007 Earnings Call TranscriptWed, Mar 12, 2008
-
AVI Biopharma Q3 2005 Earnings Conference Call Transcript (AVII)Fri, Nov 4, 2005
-
Marketwire (May 10, 2013)
-
Marketwire (Apr 18, 2013)
-
at MarketWatch.com (Apr 16, 2013)
-
at CNBC.com (Apr 15, 2013)
-
at CNBC.com (Apr 3, 2013)
-
at CNBC.com (Apr 2, 2013)
-
at CNBC.com (Mar 19, 2013)
-
at Fox Business (Feb 20, 2013)
-
at CNBC.com (Feb 20, 2013)
-
at CNBC.com (Jan 29, 2013)
-
at MarketWatch.com (Nov 27, 2012)
-
at CNBC.com (Nov 21, 2012)
-
at MarketWatch.com (Nov 13, 2012)
-
at MarketWatch.com (Nov 6, 2012)
SRPT vs. ETF Alternatives
Company Description
Sarepta Therapeutics – formerly AVI BioPharma – is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company’s diverse pipeline includes its lead program eteplirsen, for... More
